Atlas FDA

Therakos Cellex Procedural Kit

FDA premarket approval P860003/S096 · decided 2017-10-06

Approval details

PMA number
P860003
Supplement
S096
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Therakos Cellex Procedural Kit
Generic name
System, photopheresis, extracorporeal
Applicant
Therakos Development Limited
Date received
2017-09-08
Decision date
2017-10-06
Days to decision
28 days
Decision code
OK30
Product code
LNR
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Dublin
Statement
Manufacturing process change to the mold tool for the illumination plate in the CELLEX Procedural Kit.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.